Meeting
2020 Gastrointestinal Cancers Symposium
Single institutional analysis of resectable pancreatic cancer.
Authors
Jeff Wiisanen
Mayo Clinc, Rochester, MN
Jeff Wiisanen , Patrick Navin , Moustafa El Khatib , William R Bamlet , Sean P. Cleary , Robert R. McWilliams , Mark J. Truty , Thanh P. Ho , Mindy L. Hartgers , Siddhartha Yadav , Amit Mahipal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer
Track
Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 706)
Abstract #
706
Poster Bd #
K17
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
A phase II study of S-1, oxaliplatin, and nab-paclitaxel, and itraconazole aimed at conversion surgery for advanced and recurrent gastric cancer.
First Author: Yoshihiko Nakamoto
Poster
2014 Gastrointestinal Cancers Symposium
Overall survival with preoperative biliary drainage in patients with resectable pancreatic cancer.
First Author: Tobin Joel Crill Strom
Poster
2013 ASCO Annual Meeting
Clinical and prognostic features of adult patients with gangliogliomas.
First Author: Shlomit Yust-Katz
Poster
2024 ASCO Breakthrough
Clinical determinants of survival in patients with stage II-III pancreatic cancer.
First Author: Haruka Itakura